Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

U.S. Prescribing Rate Maps

About the Maps

The data in the maps show the geographic distribution in the United States, at both state and county levels, of retail opioid prescriptions dispensed per 100 persons from 2006–2016. a,b,c

Data are displayed within two types of interactive maps that show the estimated rate of opioid prescriptions per 100 U.S. residents. The state maps portray these rates for each of the 50 states plus the District of Columbia.  The county maps portray these rates for 87.6% to 93.4% of U.S. counties for a given year from 2006-2016.d

Rates are classified by the Jenkse natural breaks classification method into 4 groups using the 11-year range of data to determine the class breaks. Hover over a county or state to reveal its prescription rate or view the corresponding data table for additional information.

Key Highlights

  • After a steady increase in the overall national opioid prescribing rate from 2006, the total number of prescriptions dispensed peaked in 2012 at more than 255 million and a prescribing rate of 81.3 prescriptions per 100 persons.
  • The overall national opioid prescribing rate declined from 2012 to 2016, and in 2016, the prescribing rate had fallen to the lowest it had been in more than 10 years at 66.5 prescriptions per 100 persons (over 214 million total opioid prescriptions).
  • However, in 2016, prescribing rates continue to remain very high in areas across the country.
    • In about a quarter of U.S. counties, enough opioid prescriptions were dispensed for every person to have one.
    • While the overall opioid prescribing rate in 2016 was 66.5 prescriptions per 100 people, some counties had rates that were seven times higher than that.
  • Prescribing rates for opioids vary widely across different states and counties. Emerging hotspot areas are identified by the darker colors on the maps.

U.S. County Prescribing Rate Maps

U.S. State Prescribing Rate Maps

Table 1. Total number and rate of opioid prescriptions dispensed, United States, 2006–2016
 Year Total Number of
Prescribing Rate
Per 100 Persons
2006 215,917,663 72.4
2007 228,543,773 75.9
2008 237,860,213 78.2
2009 243,738,090 79.5
2010 251,088,904 81.2
2011 252,167,963 80.9
2012 255,207,954 81.3
2013 247,090,443 78.1
2014 240,993,021 75.6
2015 226,819,924 70.6
2016 214,881,622 66.5
Table 2. Total number and percentage of counties with available opioid prescribing data, United States, 2006–2016
Year Number of Counties
Number of Counties
(with Available Data)
Percentage of Counties
(with Available Data)
2006 3143 2754 87.6
2007 3143 2746 87.4
2008 3143 2758 87.8
2009 3143 2750 87.5
2010 3143 2741 87.2
2011 3142 2745 87.4
2012 3142 2736 87.1
2013 3142 2753 87.6
2014 3142 2960 94.2
2015 3142 2963 94.3
2016  3142 2962 94.3

Sources and Footnotes

  1. Source for all prescribing data: QuintilesIMS Transactional Data Warehouse (TDW) 2006–2016.
    QuintilesIMS TDW is based on a sample of approximately 59,000 retail (non-hospital) pharmacies, which dispense nearly 88% of all retail prescriptions in the U.S. For this database, a prescription is an initial or refill prescription dispensed at a retail pharmacy in the sample, and paid for by commercial insurance, Medicaid, Medicare, or cash or its equivalent. Does not include mail order pharmacy data.
  2. For the calculation of prescribing rates, numerators are the total number of opioid prescriptions dispensed in a given year, state, or county, as appropriate.  Annual resident population denominator estimates were obtained from the Population Estimates Program, U.S. Census Bureau. For population data, 2000–2010 Intercensal Estimates of the Resident Population for Counties and States were used for 2006–2010 rate calculations; 2010–2016 Postcensal Estimates of the Resident Population for Counties and National were used for 2011–2016.
  3. Opioid prescriptions, including butrans (buprenorphine), codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, propoxyphene, tapentadol, and tramadol were identified using the National Drug Code. Cough and cold formulations containing opioids and buprenorphine, an opioid partial agonist used for treatment of opioid use disorder as well as for pain, were not included. In addition, methadone dispensed through methadone maintenance treatment programs is not included in QuintilesIMS TDW data.
  4. Table 2 displays the percentage of counties in the U.S that have opioid prescribing rates available for a given year. A lack of available data may indicate that the county had no retail pharmacies, the county had no retail pharmacies sampled, or the prescription volume was erroneously attributed to an adjacent, more populous county according to the sampling rules used.
  5. Jenks, George F. 1967. “The Data Model Concept in Statistical Mapping,” International Yearbook of Cartography 7: 186–190.

NOTE: These maps display the number of opioid prescriptions per 100 residents, by state and county, from 2006 to 2016. These maps are distinct from the July 2017 issue of CDC Vital Signs, which featured different facets of opioid prescribing from 2006 to 2015, including the amounts of opioids prescribed (morphine milligram equivalents per capita), prescription dosages, and days supply, as well as county-level factors associated with increased amounts of opioids prescribed. For more information, visit: